Cardlytics
CDLX
138 hedge funds and large institutions have $706M invested in Cardlytics in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 55 increasing their positions, 37 reducing their positions, and 33 closing their positions.
49% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 37
8% more call options, than puts
Call options by funds: $2.33M | Put options by funds: $2.15M
0.58% less ownership
Funds ownership: 9.87% → 9.29% (-0.58%)
10% less funds holding
Funds holding: 153 → 138 (-15)
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
36% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 33
61% less capital invested
Capital invested by funds: $1.83B → $706M (-$1.13B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$12.9M |
| 2 |
BlackRock
New York
|
+$8.44M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$6.15M |
| 4 |
Two Sigma Investments
New York
|
+$6.06M |
| 5 |
Jennison Associates
New York
|
+$4.87M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$65.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$38M |
| 3 |
Rockefeller Capital Management
New York
|
-$7.09M |
| 4 |
Bank of New York Mellon
New York
|
-$5.72M |
| 5 |
ECA
Endeavour Capital Advisors
Greenwich,
Connecticut
|
-$4.19M |
CDLX Hedge Fund Activity: Q2 2022 in Review
138 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q2 2022, worth a combined $706M — down 61% from $1.83B a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of CDLX and 21 opened new positions — a net loss of 12 holders — while 37 trimmed existing stakes and 55 added.
The largest buyer was Assenagon Asset Management, opening a new position worth an estimated $12.9M. The largest seller was JP Morgan Chase, cutting an estimated $65.4M.
- 138 institutional investors held Cardlytics (CDLX) as of Q2 2022, down from 153 in Q1 2022.
- Funds reported $706M of Cardlytics stock for Q2 2022, down 61% quarter-over-quarter.
- 21 funds opened new Cardlytics positions in Q2 2022 and 33 closed out, a net change of -12 holders.
- The largest Cardlytics buyer in Q2 2022 was Assenagon Asset Management, an estimated $12.9M added.
- The largest Cardlytics seller in Q2 2022 was JP Morgan Chase, an estimated $65.4M sold.
Based on aggregated 13F filings for Q2 2022.